Skip to content
Research Article Open access CC BY 4.0

Design of COX-1 Inhibitors Utilizing Class I Isosteres, Class II Isosteres, and Nonclassical Bioisosteres for Substituent Substitution on Proved Parent Structures

Ronald Bartzatt

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–15 · Published 19 Jun 2015

10.9734/JAMPS/2015/18954

Abstract

Aims: To identify isosteres and bioisosteres suitable for substitution on the molecular scaffold of meclofenamic acid and tolfenamic acid. The compounds will be studied to determine drug-likeness and other properties. Study Design: Isosteres and bioisosteres were selected and emplaced on the scaffold of meclofenamic acid and tolfenamic acid to ascertain drug-likeness outcome. Drug candidates were selected based on favorable drug-likeness. Place and Duration of Study: Chemistry Department, University of Nebraska at Omaha, Omaha Nebraska from March 2015 to May 2015. Methodology: Two non-steroidal anti-inflammatory drugs, meclofenamic acid and tolfenamic acid, are selected based on versatile isosteres and bioisosteres substitution. Placement of class I isosteres, class II isosteres, and nonclassical bioisosteres was accomplished using molecular modeling software. Physicochemical properties were determined and compared by numerical analysis and by pattern recognition. This approach is evaluated for success in generating drug-like compounds. Results: Utilizing meclofenamic acid as parent compound, a total of 13 class I isosteres, five class II isosteres, and four non-classical bioisosteres were identified. For this group the Log P and polar surface area values ranged from 2.534 to 6.268 and 49.326 Angstroms2 to 101.372 Angstroms2, respectively. Utilizing tolfenamic acid as parent compound, a total of ten class I isosteres, five class II isosteres, and four non-classical bioisosteres were identified. For this group the range of Log P and polar surface area values were 1.904 to 5.408, and 37.299 Angstroms2 to 75.349 Angstroms2, respectively. Multiple regression analysis of properties produced equations useful for prediction of similar drugs for both groups. Conclusion: Variations of physicochemical properties by isosteres (class I and class II) and bioisosteres, successfully produced 22 of meclofenamic acid based drug designs and 19 of tolfenamic acid based drug designs. All compounds were evaluated for drug-likeness and similarities by cluster analysis. New drug designs are needed for COX-1 inhibition.  

COX-1 NSAIDs cyclooxygenase meclofenamic acid tolfenamic acid

References (26)

  1. 1 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 [DOI]
  2. 2 Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues [DOI]
  3. 3 Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics [DOI]
  4. 4 The mechanism of action of nonsteroidal antiinflammatory drugs.
  5. 5 The Mechanisms of Action of NSAIDs in Analgesia [DOI]
  6. 6 Mechanism of Action of Anti-Inflammatory Drugs [DOI]
  7. 7 Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (Review) [DOI]
  8. 8 Nonsteroidal anti-inflammatory drugs [DOI]
  9. 9 The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force [DOI]
  10. 10 NSAIDs and Chemoprevention [DOI]
  11. 11 Chemoprevention of colorectal cancer: systematic review and economic evaluation [DOI]
  12. 12 A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer Incidence [DOI]
  13. 13 Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered [DOI]
  14. 14 Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity [DOI]
  15. 15 Medicinal Chemistry : A Molecular and Biochemical Approach
  16. 16 Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer [DOI]
  17. 17 Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO) [DOI]
  18. 18 Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation [DOI]
  19. 19 Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer [DOI]
  20. 20 NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action [DOI]
  21. 21 Fundamentals of Medicinal Chemistry
  22. 22 Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study [DOI]
  23. 23 [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
  24. 24 NSAIDs Inhibit Colorectal, Oral Cancers [DOI]
  25. 25 Statistics and Data Analysis in Geology [DOI]
  26. 26 Statistics and Data Analysis in Geology. [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

57

Page views

0

PDF downloads

36

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.